PPI

Nowcasting consumer price inflation using high-frequency scanner data: evidence from Germany

Retrieved on: 
Tuesday, April 23, 2024
Consensus, Online, Cream, Honey, Tax, Glass, MAPI, Consensus Economics, Journal of Economic Perspectives, Milk, Shower, Low-alcohol beer, Autoregressive–moving-average model, Infant, C3, Islam, Wine, Core inflation, Research Papers in Economics, National accounts, Kálmán, Barcode, Journal of International Economics, Communication, Royal Statistical Society, COVID19, Kohl (cosmetics), Natural disaster, Business, Observation, Paper, VAT, European Economic Review, Diebold Nixdorf, Blancmange, Calendar, Sunflower oil, Annual Review of Economics, Hand, C4, DESTATIS, NBER, Tinning, Razor, Forecasting, Gasoline, Coffee, European Economic Association, Cat, Journal of Monetary Economics, Journal of Applied Econometrics, Medeiros, Architecture, Oxford University Press, Producer, GfK, Quarterly Journal of Economics, Margarine, NCBS, Starch, Political economy, Consistency, COVID-19, Consensus decision-making, Website, MIDAS, Behavior, Deutsche Bundesbank, PPI, World Bank, Collection, Medical classification, Orange, Eurozone, Butter, FMCG, Noise, Travel, Clothing, History, Inflation, Liver, International economics, Journal of Political Economy, BSI, OLS, Statistics, Consumer, PDF, University of Chicago, Classification, ECB, Fats, Policy, Multi, WOB, Outline, C6, Mincing, Canadian International Council, Social science, Perfume, University of California, Berkeley, Journal of Forecasting, Federal Reserve Bank, JEL, L1, Journal, Research, Candle, Food, TPD, Credit, Spice, LPG, Janssen, Marmalade, Superior, Literature, Chocolate, Beef, Kiel University, European Central Bank, Natural gas, HICP, Monetary economics, Yogurt, Section 5, ILO, Bermingham, Price, GTIN, Cheese, Macroeconomics, Growth, Beck, XJ, Government, De Beer, Supermarket, Ice cream, Naturally, C53, Corn flakes, BIS, Biscuit, LASSO, Petroleum, A.2, Poultry, Accuracy and precision, Application, White, Lettuce, Risk, ESCB, University of Siegen, OECD, Chapter One, Lipstick, Sack, XT, BIC, Garlic, Consumption, Sokol, Meat, VAR, Database, Section 3, Rusk, American Economic Journal, Royal, Curd, Overalls, Lamb, Great Lockdown, Fruit, Economy, COICOP, International Journal of Forecasting, Aftershave, Section 2, Nonparametric statistics, Attention, Conference, CPI, Heat, Public economics, Common sunflower, Nowcasting, American Economic Review, Computational Statistics (journal), GFK, COVID-19 pandemic, Exercise, Shock, Running, UNECE, Edible, Gambling, Banco, Rigid transformation, European Commission, Frozen, C.2, PRISMA, Official statistics, Concept, Drink, Transaction data, Somatosensory system, Punctuality, Altbier, Food prices, Response, GDP, Index, E31, Cabinet of Germany, Holiday, Machine learning, Series, Green, Whisky, Vegetable, Cola, Journal of Econometrics, Sadik Harchaoui, University, Aggregate, World Bank Group, B.1, Use, Book, Economic statistics, Civil service commission, 1L, Apple, Bread, Filter, Central bank, Brandeis University, Economic Modelling, Bank, Barkan, Roulade, Dairy product, Neural network, Reproduction, IMF, Section, ID, Data, D4L, Cryptocurrency
Key Points: 

    Rapafusyn Announces Multiple Presentations at the 2024 Drug Discovery Chemistry Conference

    Retrieved on: 
    Monday, April 1, 2024
    Poster, Emerging technologies, Conference, PPI, Pharmaceutical industry

    BALTIMORE, April 01, 2024 (GLOBE NEWSWIRE) -- Rapafusyn Pharmaceuticals is pleased to announce two upcoming presentations at Cambridge Health Institute’s 12th Annual Oral Peptides & Macrocyclics Conference, April 1 – 4 in San Diego.

    Key Points: 
    • BALTIMORE, April 01, 2024 (GLOBE NEWSWIRE) -- Rapafusyn Pharmaceuticals is pleased to announce two upcoming presentations at Cambridge Health Institute’s 12th Annual Oral Peptides & Macrocyclics Conference, April 1 – 4 in San Diego.
    • Dr. Rick Ewing, VP and Head of Chemistry, will be giving an oral presentation on Rapafusyn’s Non-Degradation Molecular Glue platform.
    • Dr. Sam Hong, Sr. Director and Head of Platform, will be presenting a poster on Rapafusyn’s industry-leading libraries of molecular glues.
    • We are excited to share our efforts at the Oral Peptides and Macrocyclics Conference” said Dr. Sean Hu, CEO of Rapafusyn.

    Phathom Pharmaceuticals Launches Direct-to-Consumer Campaign, “VOQUEZNA Can Kick Some Acid”

    Retrieved on: 
    Tuesday, March 26, 2024
    Connected, HIV-1, Amazon Prime Video, Breast milk, Face, Hypoesthesia, Patient, Chronic pain, Clostridioides, Heartburn, Lymph, Magnesium, Diarrhea, Myalgia, Spine, Allergy, Muscle weakness, Vonoprazan, Stomach, Vitamin, Dizziness, Potassium, Hip, Risk, Tongue, Chills, DTC, Safety, Food, PPI, Rash, Food and Drug Administration, GERD, Enzyme inhibitor, Skin, Esophagitis, HIV, Rilpivirine, Kidney, FDA, Esophagus, B-12, Weakness, Infection, Indigestion, Smart TV, Seizure, Inflammation, Polyp, Calcium, Extrapyramidal system, Bone fracture, Nausea, Spasm, Urine, Fever, Clostridioides difficile, Bleeding, Blood, Wrist, Blister, Vitamin B12, Human, Medicine, Pharmaceutical industry

    FLORHAM PARK, N.J., March 26, 2024 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announces the launch of its new broadcast ad and full-scale, Direct-to-Consumer (DTC) campaign, “VOQUEZNA Can Kick Some Acid,” to raise awareness of its powerful first-in-class treatment and encourage people to speak to their doctor about this new treatment option. VOQUEZNA (vonoprazan) is indicated for the healing and maintenance of healing of all severities of Erosive Esophagitis (EE), also referred to as Erosive GERD, and for the relief of related heartburn. VOQUEZNA represents the first major innovation to the U.S. Erosive GERD market in over 30 years.1

    Key Points: 
    • The campaign will also be featured on consumer-facing platforms across Facebook, Instagram, waiting room TVs in doctor offices, and digital banner ads.
    • “Phathom is excited to launch our first campaign directly to, and for, the people whose lives we strive to improve every day.
    • To view a video of the “VOQUEZNA Can Kick Some Acid” commercial, click here.
    • Talk with your healthcare provider about the possibility of fundic gland polyps if you have been on VOQUEZNA for a long time.

    Schwab Trading Activity Index™: Score Ascends to Moderate Levels in March

    Retrieved on: 
    Monday, April 8, 2024
    Professional Services, Business, Finance, Fintech, Asset Management, Banking, Consumer, Education, CPI, VIX, Labour, Federal Reserve, Name, STAX, S&P, Activity, Current Population Survey, Fed, PPI, Producer, Multimedia, Treasury, Consumer confidence, CBOE, Financial adviser

    The Schwab Trading Activity Index™ (STAX) increased to 51.65 in March, up from its score of 47.65 in February.

    Key Points: 
    • The Schwab Trading Activity Index™ (STAX) increased to 51.65 in March, up from its score of 47.65 in February.
    • View the full release here: https://www.businesswire.com/news/home/20240408112995/en/
      Schwab Trading Activity Index March 2024 (Graphic: Charles Schwab)
      The reading for the four-week period ending March 28, 2024 ranks “moderate” compared to historic averages and marks the highest reading since May 2022.
    • “In the face of undeniably mixed macroeconomic data, the markets soared this month, and the STAX score continued its rise in step,” said Joe Mazzola, Director of Trading and Education at Charles Schwab.
    • “Despite the market highs, however, Schwab clients remain in the moderate range of market exposure as measured by the STAX.

    nubia Flip 5G: The Epitome of Innovation in Foldable Smartphone Technology

    Retrieved on: 
    Tuesday, April 9, 2024
    EST, Smartphone, Sunshine 1530, Intelligence, HKT, 3D, Photography, DV, PPI, Creativity, Pet, Multimedia, Weather

    SHENZHEN, China, April 9, 2024 /PRNewswire/ -- nubia, a leading global smartphone manufacturer and a pioneer in innovative smartphone technology, proudly announces the launch of its groundbreaking flagship foldable smartphone, the nubia Flip 5G.

    Key Points: 
    • SHENZHEN, China, April 9, 2024 /PRNewswire/ -- nubia, a leading global smartphone manufacturer and a pioneer in innovative smartphone technology, proudly announces the launch of its groundbreaking flagship foldable smartphone, the nubia Flip 5G.
    • Tailored specifically for the younger generation, the nubia Flip 5G  fuses together cutting-edge design and powerful functionality, posed to redefine the smartphone experience.
    • The nubia Flip 5G represents a quantum leap forward in the evolution of foldable smartphones, embodying the perfect synergy of style, innovation, and intelligence.
    • nubia is pleased to announce the pricing and availability details for the eagerly awaited nubia Flip 5G in global markets.

    Gastrointestinal Therapeutics and Diagnostics Technologies and Global Markets Report 2024-2028: Growing Trend toward Screening and Preventive Care and Adoption and Approval of Biological Drugs - ResearchAndMarkets.com

    Retrieved on: 
    Friday, April 5, 2024
    Biotechnology, Pharmaceutical, Health, Medical Devices, Sanofi, Growth, Prevalence, AbbVie, Environment, Laxative, Incidence, Antacid, ESG, Gastroesophageal reflux disease, Malignancy, Constipation, Diarrhea, GI, GERD, Irritable bowel syndrome, Prescription, Inflammatory Bowel Diseases, Gastrointestinal disease, OTC, Therapy, Pancreatitis, IBS, Endoscopy, USD, PPI

    The "Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.

    Key Points: 
    • The "Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.
    • The Global Gastrointestinal Therapeutics and Diagnostics Market was valued at USD 86 Billion in 2023, and is expected to reach USD 122.5 Billion by 2028, rising at a CAGR of 7.30%.
    • This research study analyzes the GI diagnostics and therapeutics market, offers revenue forecasts, assesses future trends and provides strategic recommendations for the success of market participants.
    • This report estimates market data for 2022 (the base year) and forecasts for 2023 through 2028.

    Precision Products, Inc. Hosts U.S. Congresswoman Marjorie Taylor Greene for Facility Tour

    Retrieved on: 
    Thursday, March 28, 2024
    Automotive Manufacturing, Government Technology, Aerospace, Satellite, Manufacturing, Defense, Air, Other Science, Transport, State, Local, Other Defense, Contracts, Hardware, Electronic Design Automation, Science, Technology, Public Policy, Government, Military, Engineering, AS9100, Republican, Growth, Marjorie Taylor Greene, ISO9001, ITAR, 3D, CNC, Pleasure, PPI, Workforce, War Office Selection Boards, Mazak

    Precision Products , a woman-owned small business in Dalton, Georgia specializing in machined parts for the Defense and Aerospace industry, welcomed U.S. Congresswoman Marjorie Taylor Greene (GA. 14th district) on a tour of its facilities.

    Key Points: 
    • Precision Products , a woman-owned small business in Dalton, Georgia specializing in machined parts for the Defense and Aerospace industry, welcomed U.S. Congresswoman Marjorie Taylor Greene (GA. 14th district) on a tour of its facilities.
    • The Republican Congresswoman along with Chief of Staff Ed Buckham, and staff arrived at Precision Products Tuesday March 26th, 2024, and were greeted by Mandi Davis (CEO/Owner) and David Davis (President/Owner).
    • PPI demonstrated a new Mazak 5-Axis CNC machine that was recently added to bolster production of high precision machined parts for the U.S. Missile Defense Agency.
    • It was a pleasure having Congresswoman Greene visit Precision Products again and we thank her for the work she does in Washington on behalf of our district.

    Vehicle Management Solutions Strengthens Presence in Texas and Enters Georgia Markets

    Retrieved on: 
    Tuesday, March 26, 2024
    Other Transport, Automotive, Finance, General Automotive, Transport, Law Enforcement, Emergency Services, Professional Services, Public Policy, Government, State, Local, Fleet Management, Growth, VMS, Acquisition, PPI, Police, Lease

    Vehicle Management Solutions LLC (“VMS”), a portfolio company of Mill Point Capital LLC, (“Mill Point”) announced the acquisition of Grant Street Companies, LLC (the “Company” or “Grant Street”), a leading provider of police and private property impound (“PPI”) vehicle storage management and a subsidiary of Summit Vehicle Solutions.

    Key Points: 
    • Vehicle Management Solutions LLC (“VMS”), a portfolio company of Mill Point Capital LLC, (“Mill Point”) announced the acquisition of Grant Street Companies, LLC (the “Company” or “Grant Street”), a leading provider of police and private property impound (“PPI”) vehicle storage management and a subsidiary of Summit Vehicle Solutions.
    • The acquisition fortifies VMS’ position as the leading player in vehicle management services in Texas and marks its entry into the high-growth Georgia market.
    • "We are thrilled to welcome Grant Street Companies into the Vehicle Management Solutions family," said Kevin Corcoran, Chief Executive Officer of VMS.
    • "We firmly believe Vehicle Management Solutions is the right partner for Grant Street Companies," added Trevor Forbes, Chief Executive Officer of Summit Vehicle Solutions.

    Implantica submits U.S. FDA Premarket Approval (PMA) application for RefluxStop® (first module)

    Retrieved on: 
    Wednesday, March 27, 2024
    Cancer, PPI, CE, PMID, Patient, Internet, PMA, Literature, File, Gastroesophageal reflux disease, FDA, Certification, Pharmaceutical industry

    The U.S. FDA has agreed to a modular submission process for the RefluxStop PMA application.

    Key Points: 
    • The U.S. FDA has agreed to a modular submission process for the RefluxStop PMA application.
    • This process provides for ongoing review and feedback from the FDA as the modules are submitted.
    • The second and third (final) modules are anticipated to be submitted to the FDA in three-month intervals later this year.
    • Dr. Peter Forsell, CEO of Implantica, says, "This FDA filing is a key fundamental milestone for RefluxStop®3 and puts us in motion for the U.S. launch preparation ahead of the pending FDA approval.

    Implantica completes Human Factors Validation Study for RefluxStop™ as part of the US FDA Premarket Approval Process

    Retrieved on: 
    Tuesday, March 26, 2024
    Cancer, PPI, PMID, Gastroesophageal reflux disease, Patient, Internet, Foregut, GERD, Northwestern University, Surgeon, Certification, PMA, Literature, Human factors and ergonomics, FDA, Pharmaceutical industry

    ), a medtech company at the forefront of bringing advanced technology into the body, announces completion of the Human Factors Validation Study with 16 US surgeons as part of the US FDA Premarket Approval (PMA) process for RefluxStop™.

    Key Points: 
    • ), a medtech company at the forefront of bringing advanced technology into the body, announces completion of the Human Factors Validation Study with 16 US surgeons as part of the US FDA Premarket Approval (PMA) process for RefluxStop™.
    • In March, 16 foregut surgeons in the United States (U.S.) participated in a Human Factors Validation Study of the RefluxStop™ procedure at Northwestern University's Simulation Lab in Chicago.
    • In the next step of the study, an independent third party is evaluating the data collected during testing in Chicago.
    • Dr. Peter Forsell, CEO of Implantica, says, "We're very grateful to the independent US surgeons and healthcare professionals who participated in the Human Factors Validation study, a key milestone for the FDA approval process.